Kurabi Arwa, Pak Kwang, Lee Eun Jung, Ryan Allen F
Department of Otolaryngology, University of California San Diego, La Jolla, CA, United States.
Department of Otorhinolaryngology-Head & Neck Surgery, Jeonbuk National University School of Medicine, Jeonju, Republic of Korea.
Front Cell Neurosci. 2024 Sep 17;18:1458720. doi: 10.3389/fncel.2024.1458720. eCollection 2024.
A number of drugs are toxic to the cochlear sensory cells known as hair cells (HCs), resulting in hearing loss. Treatment with survival-promoting growth factors, antioxidants, and inhibitors of cell death pathways or proteinases have been shown to reduce HC damage in and/or animal models. Conversely, translation to humans has often been disappointing. This may be due to the complexity of intracellular damage processes. We hypothesized that combining treatments targeting different cellular processes would be more effective.
Using an model of gentamicin ototoxicity for murine cochlear hair cells, we screened all 56 possible combinations of inhibitors targeting five different cell damage mechanisms, plus the activator of one cell survival pathway, each of which have been shown to be singly effective in preventing HC loss in experimental studies. A high dose of gentamicin (200 μM) was used over three days in culture. All compounds were added at a dosage below that required for significant protection in the assay, and only this single dose was then employed. This was done so that we could more easily detect interactive, as opposed to additive, effects.
Increasing protection of hair cells was observed as combinations of compounds were increased from two to four factors, although not all combinations were equally protective. The optimal combination of four compounds consisted of an anti-oxidant, an apoptosis inhibitor, an autophagy inhibitor and a protective growth factor. Increasing the number of factors to five or six resulted in decreased protection.
The results support the hypothesis that targeting multiple cellular damage or survival pathways provides more an effective hair cell protection approach. The results help to identify critical interactions among the cellular processes that operate in gentamicin ototoxicity. They also suggest that inhibiting too many biological processes impairs functions critical to HC survival, resulting in decreased protection.
许多药物对被称为毛细胞(HCs)的耳蜗感觉细胞有毒性,可导致听力损失。在体外和/或动物模型中,使用促进存活的生长因子、抗氧化剂以及细胞死亡途径或蛋白酶的抑制剂进行治疗,已显示可减少毛细胞损伤。相反,向人体的转化往往令人失望。这可能是由于细胞内损伤过程的复杂性所致。我们推测,联合针对不同细胞过程的治疗方法可能会更有效。
利用庆大霉素耳毒性的体外模型研究小鼠耳蜗毛细胞,我们筛选了针对五种不同细胞损伤机制的抑制剂与一种细胞存活途径激活剂的所有56种可能组合,每种在实验研究中均已显示单独使用对预防毛细胞损失有效。在培养过程中,连续三天使用高剂量庆大霉素(200μM)。所有化合物均以低于该测定中显著保护所需的剂量添加,然后仅使用这一单一剂量。这样做是为了我们能够更轻松地检测相互作用而非相加作用。
随着化合物组合从两种增加到四种因素,观察到对毛细胞的保护作用增强,尽管并非所有组合的保护效果都相同。四种化合物的最佳组合包括一种抗氧化剂、一种凋亡抑制剂、一种自噬抑制剂和一种保护性生长因子。将因素数量增加到五个或六个会导致保护作用降低。
结果支持这样的假设,即针对多种细胞损伤或存活途径可提供更有效的毛细胞保护方法。这些结果有助于确定在庆大霉素耳毒性中起作用的细胞过程之间的关键相互作用。它们还表明,抑制过多的生物学过程会损害对毛细胞存活至关重要的功能,从而导致保护作用降低。